从癌症中取出一个BiTE
1Kimberly Malkowski is an oncology treatment nurse at UPMC Hillman Cancer Center and a member of the Nursing2025 Editorial Board.
Nursing
|March 24, 2025
概括
塔拉塔马布是第一个被批准用于小细胞肺癌的双特异性T细胞吸引剂 (BiTE) 疗法. 这种新的治疗方法针对三角形状联体3抗原,激活T细胞来对抗固体瘤.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 药理学 药理学是指药理学的学科.
背景情况:
- 小细胞肺癌 (SCLC) 仍然是一个具有挑战性的固体瘤,治疗选择有限.
- 双特异性T细胞吸引剂 (BiTE) 疗法代表了癌症治疗的新方法.
- 塔拉他马布-dlle是一种新批准的 BiTE 治疗SCLC的疗法.
研究的目的:
- 推出Tarlatamab (tarlatamab-dlle) 作为第一个批准的双特异性T细胞吸引剂 (BiTE) 治疗固体瘤的治疗方法.
- 解释Tarlatamab的作用机制,向三角形状联体3 (DLL3) 抗原.
- 为了突出必要的盒子警告和预防措施,为护士管理BiTE治疗.
主要方法:
- 讨论BiTE治疗原理和作用机制.
- 对Tarlatamab针对DLL3在瘤细胞上的向方法的审查.
- 检查安全配置文件,包括盒式警告和预防措施.
主要成果:
- 塔拉塔马布-德尔是首个批准用于固体瘤的BiTE疗法,特别是SCLC.
- 该疗法激活患者的T细胞以准DLL3.3表达的瘤细胞.
- 为医疗保健提供者确定关键安全考虑因素.
结论:
- 塔拉塔马布-德勒标志着其新的BiTE机制在SCLC治疗中的突破.
- 了解BiTE治疗及其相关警告对于有效和安全的患者护理至关重要.
- 护士在管理接受这种创新免疫疗法的患者中发挥着至关重要的作用.
更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.7K
09:20Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
8.3K
相关概念视频
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Cancer Prevention
6.0K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.0K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Tumor Immunotherapy
450
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
450
Cancer Vaccines
310
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
310
